Enhancement of human immunodeficiency virus (HIV)-specific CD8+ T cells in cerebrospinal fluid compared to those in blood among antiretroviral therapy-naïve HIV-positive subjects

Journal of Virology

Volumn 82, Issue 21, 2008, Pages 10418-10428

  Sadagopal, Shanmugalakshmi ^a   Lorey, Shelly L ^a   Barnett, Louise ^a   Basham, Rebecca ^a   Lebo, Laurie ^a   Erdem, Husamettin ^a   Haman, Kirsten ^a   Avison, Malcolm ^a,b   Waddell, Kevin ^a   Haas, David W ^a,b   Kalams, Spyros A ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD45RO ANTIGEN; CHEMOKINE RECEPTOR CCR7; GAMMA INTERFERON; LEUKOCYTE ANTIGEN; CCR7 PROTEIN, HUMAN; CD45 ANTIGEN; VIRUS RNA;

ARTICLE; BLOOD; CD8+ T LYMPHOCYTE; CELLULAR DISTRIBUTION; CEREBROSPINAL FLUID; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE COUNT; LYMPHOCYTE MIGRATION; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; VIRUS LOAD; ADULT; BIOSYNTHESIS; BRAIN; CELL PROLIFERATION; CHEMISTRY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; PHYSIOLOGY; RADIOGRAPHY; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

ADULT; ANTIGENS, CD45; BLOOD; BRAIN; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CEREBROSPINAL FLUID; HIV INFECTIONS; HIV-1; HUMANS; INTERFERON TYPE II; RECEPTORS, CCR7; RNA, VIRAL; VIRAL LOAD;

EID: 55249089046     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01190-08     Document Type: Article

References (86)

1. Addo, M. M., X. G. Yu, A. Rathod, D. Cohen, R. L. Eldridge, D. Strick, M. N. Johnston, C. Corcoran, A. G. Wurcel, C. A. Fitzpatrick, M. E. Feeney, W. R. Rodriguez, N. Basgoz, R. Draenert, D. R. Stone, C. Brander, P. J. Goulder, E. S. Rosenberg, M. Altfeld, and B. D. Walker. 2003. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J. Virol. 77:2081-2092.
2. + T cells during supervised treatment interruptions in chronic HIV-1 infection. J. Clin. Investig. 109:837-843.
3. Baenziger, J., H. Hengartner, R. M. Zinkernagel, and G. A. Cole. 1986. Induction or prevention of immunopathological disease by cloned cytotoxic T cell lines specific for lymphocytic choriomeningitis virus. Eur. J. Immunol. 16:387-393.
4. Bagetta, G., M. T. Corasaniti, A. M. Paoletti, L. Berliocchi, R. Nistico, A. M. Giammarioli, W. Malorni, and A. Finazzi-Agro. 1998. HIV-1 gp120-induced apoptosis in the rat neocortex involves enhanced expression of cyclo-oxygenase type 2 (COX-2). Biochem. Biophys. Res. Commun. 244:819-824.
5. Barks, J. D., X. H. Liu, R. Sun, and F. S. Silverstein. 1997. gp120, a human immunodeficiency virus-1 coat protein, augments excitotoxic hippocampal injury in perinatal rats. Neuroscience 76:397-409.
6. Bell, J. E. 1998. The neuropathology of adult HIV infection. Rev. Neurol. (Paris) 154:816-829.
7. Bell, J. E., R. P. Brettle, A. Chiswick, and P. Simmonds. 1998. HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS. Effect of neocortical involvement. Brain 121:2043-2052.
8. Bell, J. E., A. Busuttil, J. W. Ironside, S. Rebus, Y. K. Donaldson, P. Simmonds, and J. F. Peutherer. 1993. Human immunodeficiency virus and the brain: investigation of virus load and neuropathologic changes in pre-AIDS subjects. J. Infect. Dis. 168:818-824.
9. + T-cell responses: relationship to viral load in untreated HIV infection. J. Virol. 75:11983-11991.
10. Bihl, F. K., E. Loggi, J. V. Chisholm III, H. S. Hewitt, L. M. Henry, C. Linde, T. J. Suscovich, J. T. Wong, N. Frahm, P. Andreone, and C. Brander. 2005. Simultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti-CD3 mAb T-cell expansion and "RecycleSpot." J. Transl. Med. 3:20.
11. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68:6103-6110.
12. Brana, C., T. E. Biggs, C. H. Barton, L. E. Sundstrom, and D. A. Mann. 1999. A soluble factor produced by macrophages mediates the neurotoxic effects of HIV-1 Tat in vitro. AIDS 13:1443-1452.
13. Brew, B. J., M. Rosenblum, K. Cronin, and R. W. Price. 1995. AIDS dementia complex and HIV-1 brain infection: clinical-virological correlations. Ann. Neurol. 38:563-570.
14. Brodie, S. J., B. K. Patterson, D. A. Lewinsohn, K. Diem, D. Spach, P. D. Greenberg, S. R. Riddell, and L. Corey. 2000. HIV-specific cytotoxic T lymphocytes traffic to lymph nodes and localize at sites of HIV replication and cell death. J. Clin. Investig. 105:1407-1417.
15. Budka, H., G. Costanzi, S. Cristina, A. Lechi, C. Parravicini, R. Trabattoni, and L. Vago. 1987. Brain pathology induced by infection with the human immunodeficiency virus (HIV). A histological, immunocytochemical, and electron microscopical study of 100 autopsy cases. Acta Neuropathol. 75: 185-198.
16. Chakrabarti, L., M. Hurtrel, M. A. Maire, R. Vazeux, D. Dormont, L. Montagnier, and B. Hurtrel. 1991. Early viral replication in the brain of SIV-infected rhesus monkeys. Am. J. Pathol. 139:1273-1280.
17. Chan, W. L., T. Javanovic, and M. L. Lukic. 1989. Infiltration of immune T cells in the brain of mice with herpes simplex virus-induced encephalitis. J. Neuroimmunol. 23:195-201.
18. Chien, J. W., H. Valdez, G. McComsey, D. McClernon, M. St Clair, and M. M. Lederman. 1999. Presence of mutation conferring resistance to lamivudine in plasma and cerebrospinal fluid of HIV-1-infected patients. J. Acquir. Immune Defic. Syndr. 21:277-280.
19. Cinque, P., S. Presi, A. Bestetti, C. Pierotti, S. Racca, E. Boeri, P. Morelli, P. Carrera, M. Ferrari, and A. Lazzarin. 2001. Effect of genotypic resistance on the virological response to highly active antiretroviral therapy in cerebrospinal fluid. AIDS Res. Hum. Retrovir. 17:377-383.
20. Corasaniti, M. T., M. C. Strongoli, S. Piccirilli, R. Nistico, A. Costa, A. Bilotta, P. Turano, A. Finazzi-Agro, and G. Bagetta. 2000. Apoptosis induced by gp120 in the neocortex of rat involves enhanced expression of cyclooxygenase type 2 and is prevented by NMDA receptor antagonists and by the 21-aminosteroid U-74389G. Biochem. Biophys. Res. Commun. 274:664-669.
21. Davis, L. E., B. L. Hjelle, V. E. Miller, D. L. Palmer, A. L. Llewellyn, T. L. Merlin, S. A. Young, R. G. Mills, W. Wachsman, and C. A. Wiley. 1992. Early viral brain invasion in iatrogenic human immunodeficiency virus infection. Neurology 42:1736-1739.
22. Di Stefano, M., F. Sabri, T. Leitner, B. Svennerholm, L. Hagberg, G. Norkrans, and F. Chiodi. 1995. Reverse transcriptase sequence of paired isolates of cerebrospinal fluid and blood from patients infected with human immunodeficiency virus type 1 during zidovudine treatment. J. Clin. Microbiol. 33:352-355.
23. Ellis, R. J., K. Hsia, S. A. Spector, J. A. Nelson, R. K. Heaton, M. R. Wallace, I. Abramson, J. H. Atkinson, I. Grant, J. A. McCutchan, et al. 1997. Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. Ann. Neurol. 42:679-688.
24. Enting, R. H., R. M. Hoetelmans, J. M. Lange, D. M. Burger, J. H. Beijnen, and P. Portegies. 1998. Antiretroviral drugs and the central nervous system. AIDS 12:1941-1955.
25. Fujimura, R. K., K. Goodkin, C. K. Petito, R. Douyon, D. J. Feaster, M. Concha, and P. Shapshak. 1997. HIV-1 proviral DNA load across neuroanatomic regions of individuals with evidence for HIV-1-associated dementia. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 16:146-152.
26. Gabuzda, D. H., D. D. Ho, S. M. de la Monte, M. S. Hirsch, T. R. Rota, and R. A. Sobel. 1986. Immunohistochemical identification of HTLV-III antigen in brains of patients with AIDS. Ann. Neurol. 20:289-295.
27. Galea, I., M. Bernardes-Silva, P. A. Forse, N. van Rooijen, R. S. Liblau, and V. H. Perry. 2007. An antigen-specific pathway for CD8 T cells across the blood-brain barrier. J. Exp. Med. 204:2023-2030.
28. Gartner, S. 2000. HIV infection and dementia. Science 287:602-604.
29. Gatanaga, H., S. Oka, S. Ida, T. Wakabayashi, T. Shioda, and A. Iwamoto. 1999. Active HIV-1 redistribution and replication in the brain with HIV encephalitis. Arch. Virol. 144:29-43.
30. Goudsmit, J., F. de Wolf, D. A. Paul, L. G. Epstein, J. M. Lange, W. J. Krone, H. Speelman, E. C. Wolters, J. Van der Noordaa, J. M. Oleske, et al. 1986. Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection. Lancet ii:177-180.
31. Griffin, D. E. 2003. Immune responses to RNA-virus infections of the CNS. Nat. Rev. Immunol. 3:493-502.
32. + T-cell function in mucosal and systemic compartments of simian immunodeficiency virus mac251- and simian-human immunodeficiency virus KU2-infected macaques. J. Virol. 75:11483-11495.
33. Helbert, M. R., J. Walter, J. L'Age, and P. C. Beverley. 1997. HIV infection of CD45RA+ and CD45RO+ CD4+ T cells. Clin. Exp. Immunol. 107:300-305.
34. Hesselgesser, J., D. Taub, P. Baskar, M. Greenberg, J. Hoxie, D. L. Kolson, and R. Horuk. 1998. Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1 alpha is mediated by the chemokine receptor CXCR4. Curr. Biol. 8:595-598.
35. Ho, D. D., M. G. Sarngadharan, L. Resnick, F. Dimarzoveronese, T. R. Rota, and M. S. Hirsch. 1985. Primary human T-lymphotropic virus type III infection. Ann. Intern. Med. 103:880-883.
36. Horton, H., I. Frank, R. Baydo, E. Jalbert, J. Penn, S. Wilson, J. P. McNevin, M. D. McSweyn, D. Lee, Y. Huang, S. C. De Rosa, and M. J. McElrath. 2006. Preservation of T cell proliferation restricted by protective HLA alleles is critical for immune control of HIV-1 infection. J. Immunol. 177:7406-7415.
37. Jacobson, S., H. Shida, D. E. McFarlin, A. S. Fauci, and S. Koenig. 1990. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature 348:245-248.
38. Jassoy, C., R. P. Johnson, B. A. Navia, J. Worth, and B. D. Walker. 1992. Detection of a vigorous HIV-1-specific cytotoxic T lymphocyte response in cerebrospinal fluid from infected persons with AIDS dementia complex. J. Immunol. 149:3113-3119.
39. Jin, X., D. E. Bauer, S. E. Tuttleton, S. Lewin, A. Gettie, J. Blanchard, C. E. Irwin, J. T. Safrit, J. Mittler, L. Weinberger, L. G. Kostrikis, L. Zhang, A. S. Perelson, and D. D. Ho. 1999. Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J. Exp. Med. 189:991-998.
40. Kim, R. B., M. F. Fromm, C. Wandel, B. Leake, A. J. Wood, D. M. Roden, and G. R. Wilkinson. 1998. The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. J. Clin. Investig. 101:289-294.
41. Kim, W. K., S. Corey, G. Chesney, H. Knight, S. Klumpp, C. Wuthrich, N. Letvin, I. Koralnik, A. Lackner, R. Veasey, and K. Williams. 2004. Identification of T lymphocytes in simian immunodeficiency virus encephalitis: distribution of CD8+ T cells in association with central nervous system vessels and virus. J. Neurovirol. 10:315-325.
42. Klavinskis, L. S., A. Tishon, and M. B. Oldstone. 1989. Efficiency and effectiveness of cloned virus-specific cytotoxic T lymphocytes in vivo. J. Immunol. 143:2013-2016.
43. Koup, R. A., J. T. Safrit, Y. Cao, C. A. Andrews, G. McLeod, W. Borkowsky, C. Farthing, and D. D. Ho. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68:4650-4655.
44. Kreth, H. W., L. Kress, H. G. Kress, H. F. Ott, and G. Eckert. 1982. Demonstration of primary cytotoxic T cells in venous blood and cerebrospinal fluid of children with mumps meningitis. J. Immunol. 128:2411-2415.
45. Kure, K., K. M. Weidenheim, W. D. Lyman, and D. W. Dickson. 1990. Morphology and distribution of HIV-1 gp41-positive microglia in subacute AIDS encephalitis. Pattern of involvement resembling a multisystem degeneration. Acta Neuropathol. 80:393-400.
46. Kuroda, M. J., J. E. Schmitz, A. Seth, R. S. Veazey, C. E. Nickerson, M. A. Lifton, P. J. Dailey, M. A. Forman, P. Racz, K. Tenner-Racz, and N. L. Letvin. 2000. Simian immunodeficiency virus-specific cytotoxic T lymphocytes and cell-associated viral RNA levels in distinct lymphoid compartments of SIVmac-infected rhesus monkeys. Blood 96:1474-1479.
47. Lazarini, F., D. Seilhean, O. Rosenblum, S. Suarez, L. Conquy, T. Uchihara, V. Sazdovitch, K. Mokhtari, T. Maisonobe, F. Boussin, C. Katlama, F. Bricaire, C. Duyckaerts, and J. J. Hauw. 1997. Human immunodeficiency virus type 1 DNA and RNA load in brains of demented and nondemented patients with acquired immunodeficiency syndrome. J. Neurovirol. 3:299-303.
48. Letendre, S. L., J. A. McCutchan, M. E. Childers, S. P. Woods, D. Lazzaretto, R. K. Heaton, I. Grant, and R. J. Ellis. 2004. Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders. Ann. Neurol. 56:416-423.
49. Ma, M., and A. Nath. 1997. Molecular determinants for cellular uptake of Tat protein of human immunodeficiency virus type 1 in brain cells. J. Virol. 71:2495-2499.
50. Marcondes, M. C., E. M. Burudi, S. Huitron-Resendiz, M. Sanchez-Alavez, D. Watry, M. Zandonatti, S. J. Henriksen, and H. S. Fox. 2001. Highly activated CD8(+) T cells in the brain correlate with early central nervous system dysfunction in simian immunodeficiency virus infection. J. Immunol. 167:5429-5438.
51. Matano, T., R. Shibata, C. Siemon, M. Connors, H. C. Lane, and M. A. Martin. 1998. Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques. J. Virol. 72:164-169.
52. McArthur, J. C., D. R. McClernon, M. F. Cronin, T. E. Nance-Sproson, A. J. Saah, M. St Clair, and E. R. Lanier. 1997. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain. Ann. Neurol. 42:689-698.
53. McCoig, C., M. M. Castrejon, E. Castano, O. De Suman, C. Baez, W. Redondo, D. McClernon, S. Danehower, E. R. Lanier, C. Richardson, A. Keller, S. Hetherington, X. Saez-Llorens, and O. Ramilo. 2002. Effect of combination antiretroviral therapy on cerebrospinal fluid HIV RNA, HIV resistance, and clinical manifestations of encephalopathy. J. Pediatr. 141:36-44.
54. Migueles, S. A., A. C. Laborico, W. L. Shupert, M. S. Sabbaghian, R. Rabin, C. W. Hallahan, D. Van Baarle, S. Kostense, F. Miedema, M. McLaughlin, L. Ehler, J. Metcalf, S. Liu, and M. Connors. 2002. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat. Immunol. 3:1061-1068.
55. Migueles, S. A., M. S. Sabbaghian, W. L. Shupert, M. P. Bettinotti, F. M. Marincola, L. Martino, C. W. Hallahan, S. M. Selig, D. Schwartz, J. Sullivan, and M. Connors. 2000. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc. Natl. Acad. Sci. USA 97:2709-2714.
56. + T cells in the central nervous system of macaques chronically infected with simian immunodeficiency virus SIVmac251. J. Virol. 77:12346-12351.
57. Nath, A., K. Psooy, C. Martin, B. Knudsen, D. S. Magnuson, N. Haughey, and J. D. Geiger. 1996. Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic. J. Virol. 70:1475-1480.
58. Neuenburg, J. K., T. A. Cho, A. Nilsson, B. M. Bredt, S. J. Hebert, R. M. Grant, and R. W. Price. 2005. T-cell activation and memory phenotypes in cerebrospinal fluid during HIV infection. J. Acquir. Immune Defic. Syndr. 39:16-22.
59. Neuen-Jacob, E., G. Arendt, B. Wendtland, B. Jacob, M. Schneeweis, and W. Wechsler. 1993. Frequency and topographical distribution of CD68-positive macrophages and HIV-1 core proteins in HIV-associated brain lesions. Clin. Neuropathol. 12:315-324.
60. New, D. R., M. Ma, L. G. Epstein, A. Nath, and H. A. Gelbard. 1997. Human immunodeficiency virus type 1 Tat protein induces death by apoptosis in primary human neuron cultures. J. Neurovirol. 3:168-173.
61. Nuovo, G. J., and M. L. Alfieri. 1996. AIDS dementia is associated with massive, activated HIV-1 infection and concomitant expression of several cytokines. Mol. Med. 2:358-366.
62. O'Brien, S. J., X. Gao, and M. Carrington. 2001. HLA and AIDS: a cautionary tale. Trends Mol. Med. 7:379-381.
63. Persidsky, Y., and L. Poluektova. 2006. Immune privilege and HIV-1 persistence in the CNS. Immunol. Rev. 213:180-194.
64. Provencher, S. W. 1993. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn. Reson. Med. 30:672-679.
65. Resnick, L., J. R. Berger, P. Shapshak, and W. W. Tourtellotte. 1988. Early penetration of the blood-brain-barrier by HIV. Neurology 38:9-14.
66. Roberts, E. S., S. Huitron-Resendiz, M. A. Taffe, M. C. Marcondes, C. T. Flynn, C. M. Lanigan, J. A. Hammond, S. R. Head, S. J. Henriksen, and H. S. Fox. 2006. Host response and dysfunction in the CNS during chronic simian immunodeficiency virus infection. J. Neurosci. 26:4577-4585.
67. Schmitz, J. E., M. J. Kuroda, S. Santra, V. G. Sasseville, M. A. Simon, M. A. Lifton, P. Racz, K. Tenner-Racz, M. Dalesandro, B. J. Scallon, J. Ghrayeb, M. A. Forman, D. C. Montefiori, E. P. Rieber, N. L. Letvin, and K. A. Reimann. 1999. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 283:857-860.
68. Schmitz, J. E., M. J. Kuroda, R. S. Veazey, A. Seth, W. M. Taylor, C. E. Nickerson, M. A. Lifton, P. J. Dailey, M. A. Forman, P. Racz, K. Tenner-Racz, and N. L. Letvin. 2000. Simian immunodeficiency virus (SIV)-specific CTL are present in large numbers in livers of SIV-infected rhesus monkeys. J. Immunol. 164:6015-6019.
69. Shacklett, B. L., C. A. Cox, D. T. Wilkens, R. Karl Karlsson, A. Nilsson, D. F. Nixon, and R. W. Price. 2004. Increased adhesion molecule and chemokine receptor expression on CD8+ T cells trafficking to cerebrospinal fluid in HIV-1 infection. J. Infect. Dis. 189:2202-2212.
70. Siddique, M. A., K. E. Hartman, E. Dragileva, M. Dondero, T. Gebretsadik, A. Shintani, L. Peiperl, F. Valentine, and S. A. Kalams. 2006. Low CD4+ T cell nadir is an independent predictor of lower HIV-specific immune responses in chronically HIV-1-infected subjects receiving highly active antiretroviral therapy. J. Infect. Dis. 194:661-665.
71. Sobel, R. A., A. B. Collins, R. B. Colvin, and A. K. Bhan. 1986. The in situ cellular immune response in acute herpes simplex encephalitis. Am. J. Pathol. 125:332-338.
72. Sopper, S., U. Sauer, S. Hemm, M. Demuth, J. Muller, C. Stahl-Hennig, G. Hunsmann, V. ter Meulen, and R. Dorries. 1998. Protective role of the virus-specific immune response for development of severe neurologic signs in simian immunodeficiency virus-infected macaques. J. Virol. 72:9940-9947.
73. Stevceva, L., B. Kelsall, J. Nacsa, M. Moniuszko, Z. Hel, E. Tryniszewska, and G. Franchini. 2002. Cervicovaginal lamina propria lymphocytes: phenotypic characterization and their importance in cytotoxic T-lymphocyte responses to simian immunodeficiency virus SIVmac251. J. Virol. 76:9-18.
74. Svenningsson, A., G. K. Hansson, O. Andersen, R. Andersson, M. Patarroyo, and S. Stemme. 1993. Adhesion molecule expression on cerebrospinal fluid T lymphocytes: evidence for common recruitment mechanisms in multiple sclerosis, aseptic meningitis, and normal controls. Ann. Neurol. 34:155-161.
75. Tang, Y. W., J. T. Huong, R. M. Lloyd, Jr., P. Spearman, and D. W. Haas. 2000. Comparison of human immunodeficiency virus type 1 RNA sequence heterogeneity in cerebrospinal fluid and plasma. J. Clin. Microbiol. 38:4637-4639.
76. Tashima, K. T., T. P. Flanigan, J. Kurpewski, S. M. Melanson, and P. R. Skolnik. 2002. Discordant human immunodeficiency virus type 1 drug resistance mutations, including K103N, observed in cerebrospinal fluid and plasma. Clin. Infect. Dis. 35:82-83.
77. van't Wout, A. B., L. J. Ran, C. L. Kuiken, N. A. Kootstra, S. T. Pals, and H. Schuitemaker. 1998. Analysis of the temporal relationship between human immunodeficiency virus type 1 quasispecies in sequential blood samples and various organs obtained at autopsy. J. Virol. 72:488-496.
78. Venturi, G., M. Catucci, L. Romano, P. Corsi, F. Leoncini, P. E. Valensin, and M. Zazzi. 2000. Antiretroviral resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples. J. Infect. Dis. 181:740-745.
79. von Geldern, G., S. Cepok, T. Nolting, Y. Du, V. Grummel, O. Adams, H. P. Hartung, G. Arendt, and B. Hemmer. 2007. CD8 T-cell subsets and viral load in the cerebrospinal fluid of therapy-naive HIV-infected individuals. AIDS 21:250-253.
80. von Herrath, M., M. B. Oldstone, and H. S. Fox. 1995. Simian immunodeficiency virus (SIV)-specific CTL in cerebrospinal fluid and brains of SIV-infected rhesus macaques. J. Immunol. 154:5582-5589.
81. Wiley, C. A., and C. Achim. 1994. Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome. Ann. Neurol. 36:673-676.
82. Wiley, C. A., M. Baldwin, and C. L. Achim. 1996. Expression of HIV regulatory and structural mRNA in the central nervous system. AIDS 10:843-847.
83. Wiley, C. A., V. Soontornniyomkij, L. Radhakrishnan, E. Masliah, J. Mellors, S. A. Hermann, P. Dailey, and C. L. Achim. 1998. Distribution of brain HIV load in AIDS. Brain Pathol. 8:277-284.
84. Williams, K., S. Westmoreland, J. Greco, E. Ratai, M. Lentz, W. K. Kim, R. A. Fuller, J. P. Kim, P. Autissier, P. K. Sehgal, R. F. Schinazi, N. Bischofberger, M. Piatak, J. D. Lifson, E. Masliah, and R. G. Gonzalez. 2005. Magnetic resonance spectroscopy reveals that activated monocytes contribute to neuronal injury in SIV neuroAIDS. J. Clin. Investig. 115:2534-2545.
85. Williams, K. C., S. Corey, S. V. Westmoreland, D. Pauley, H. Knight, C. deBakker, X. Alvarez, and A. A. Lackner. 2001. Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS. J. Exp. Med. 193:905-915.
86. Williams, K. C., and W. F. Hickey. 2002. Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS. Annu. Rev. Neurosci. 25:537-562.